|Catch Charles on Wednesday morning with Bill Handle at 8:20am Pacific. Charles invites his KFI listeners to take a free trial! Click here to sign up!
Jan 18 - Click here to listen to the show!
Wall Street Strategies, Inc. is an independent stock market research company.
Our daily goal is to help our subscribers make money in the stock market. Our unbiased approach is coupled with personalized service that guides investors throughout the entire life cycle of each trade. Learn more
Get our opinion on any stock in your portfolio. Find out why Charles Payne is the most popular independent analyst on Wall Street.
>> GET A PORTFOLIO REVIEW ON THE STOCK OF YOUR CHOICE
We believe investors should take an approach to the stock market based first and foremost on understanding the stocks in their portfolios beyond the chart formation.
The key to long term success isn't picking winning stocks but knowing which stock picks to hold onto during adverse conditions. Learn more.
Our approach to investment advice focuses on a balanced allocation of funds, industry exposure, and realistic expectations. 70% of your stock portfolio should be in core positions while 30% should try to generate cash actively. Learn more.
Charles Payne's Market Commentary
So, It Begins
1/23/2017 - The Death of Socrates (oil on canvas) was painted in 1787 by
Jacques-Louis David, father of Neoclassicism. It not only
reflects the tale of the philosopherís fight against the
government, which included drinking a cup of hemlock rather
than taking opportunities to escape.†
The painting reflects the mood of the French people on the
eve of The Revolution and inspired by the signing of the
Constitution in America. According to art historians,
Socrates presented a ...
Get FREE Stock Market Commentary! | Take a free trial
|Recent commentary from Charles
New POTUS New Day
1/20/2017 1:24:01 PM By Charles Payne, CEO & Principal Analyst
Happy Inauguration Day
1/20/2017 7:53:00 AM By Charles Payne, CEO & Principal Analyst
This Is Just The Calm...
1/19/2017 9:13:56 AM By Charles Payne, CEO & Principal Analyst
Lots of Data
1/18/2017 1:55:23 PM By Charles Payne, CEO & Principal Analyst
Trump Takes Victory Lap - Too Much Too Soon?
1/18/2017 9:32:13 AM By Charles Payne, CEO & Principal Analyst
Roadmap For Investing SuccessThe market is soaring and if you want a piece of the action, you should take the plunge without taking too much of a risk.† Well, youíre not alone. However, I must say that the idea of making a lot of money with no risk is typically called a confidence trick or a Ponzi scheme. These days, itís Read more.
Wall Street Strategies' Latest Articles
Several Trains Pulling Out of the Station1/20/2017 By Charles Payne, CEO & Principal Analyst
There are more signs that the U.S. economy is ready to take off like a rocket, which comes from the Philadelphia Federal Reserve Manufacturing Report. This saw all facets of the report rising sharply Read more
Ignore Sell The Inauguration1/20/2017 By Charles Payne, CEO & Principal Analyst
For the individual investor, bullishness peaked just two weeks after the election at 49.9%. And since then, itís drifted until the past week when it actually plunged almost 7%.†The market covered†a lo Read more
Big Business Gets Hip To Trump1/18/2017 By Charles Payne, CEO & Principal Analyst
I applaud the way President-elect Donald Trump has employed Twitter and social media to create a new omnipotent bully-pulpit. I am beginning to wonder if big business is getting hip by playing the public relations game instead of making serious business adjustments. Read more
Leveling the Playing Field1/13/2017 By Charles Payne, CEO & Principal Analyst
Donald Trump ran on a platform of fewer government regulations and leveling the global playing field for American businesses. Comments from Delta set up a great and long overdue showdown Ė we will see Read more
Trump's Extraordinary Press Conference1/12/2017 By Charles Payne, CEO & Principal Analyst
It was an extraordinary news conference that made for an extraordinary session for the stock market. Naturally, his comments on spending and the need for new bidding procedures spooked drug and biotechnology stocks. Read more
Drug Companies Under Fire1/12/2017 By Charles Payne, CEO & Principal Analyst
I have been to drug manufacturing facilities, and itís mostly mashing powder into pills. Itís not rocket science, so it is surprising how much of the U.S. drug company production is done outside the U Read more
MAIN STREET WISDOM
Observations of a concerned public
Bill Baumner writes:Very well written with exceptionally good perception which provides for balance in understanding accurately, the current conditions in the market, economy and media. Thank you Charles!
Voice your comments, ideas or frustrations!
Trump Rally Report
In this free 10 page special report, Investing and President Trump, Charles looks at what the winning sectors and trades
will be in the Trump Rally. The 2016 election post-mortem has created a narrative that everyone is shocked at Donald Trump's
win, including "the markets". I don't agree. Read more